Katelyn Brown
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 2%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 9
- Diabetes Management and Research 3
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 1
-
- Metabolism, Diabetes, and Cancer 4
- Co-authors
- Laura Fernández Landó (9 shared papers)Juan P. Frías (8 shared papers)Xuewei Cui (4 shared papers)Bing Liu (1 shared paper)Julio Rosenstock (3 shared papers)Federico C. Pérez Manghi (2 shared papers)Brandon K. Bergman (3 shared papers)Melanie J. Davies (3 shared papers)
- Journals
- The FASEB Journal (2 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)Cardiovascular Diabetology (2 papers)Diabetes (2 papers)Diabetes Obesity and Metabolism (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Katelyn Brown
23 papers receiving 1.9k citations
Katelyn Brown's Hit Papers
Peers
Comparison fields: 5 of 89
- Endocrinology, Diabetes and Metabolism 1.2k
- Pharmacology 420
- Physiology 326
- Endocrine and Autonomic Systems 64
- Surgery 346
Countries citing papers authored by Katelyn Brown
This map shows the geographic impact of Katelyn Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katelyn Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katelyn Brown more than expected).
Fields of papers citing papers by Katelyn Brown
This network shows the impact of papers produced by Katelyn Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katelyn Brown. The network helps show where Katelyn Brown may publish in the future.
Co-authors
The 25 scholars most cited alongside Katelyn Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes Hit paper breakdown → | 2021 | 1229 |
| 2 | Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial Hit paper breakdown → | 2021 | 447 |
| 3 | 2017 | 91 | |
| 4 | 2023 | 39 | |
| 5 | 2023 | 25 | |
| 6 | 2015 | 23 | |
| 7 | 2018 | 17 | |
| 8 | 2024 | 14 | |
| 9 | 2023 | 10 | |
| 10 | 2018 | 9 | |
| 11 | 2016 | 8 | |
| 12 | 2023 | 5 | |
| 13 | 2021 | 5 | |
| 14 | 2024 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2021 | 3 | |
| 17 | 2023 | 2 | |
| 18 | 2021 | 2 | |
| 19 | 2021 | 2 | |
| 20 | 2024 | 1 |
About Katelyn Brown
Katelyn Brown is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Public Health, Environmental and Occupational Health, Education and Human-Computer Interaction, having authored 23 papers that have together received 1.9k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (9 papers), Metabolism, Diabetes, and Cancer (4 papers), Diabetes Management and Research (3 papers), Anatomy and Medical Technology (2 papers), Virtual Reality Applications and Impacts (2 papers), Simulation-Based Education in Healthcare (1 paper), Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Pharmacology (420 citations), Physiology (326 citations), Endocrine and Autonomic Systems (64 citations) and Surgery (346 citations). Katelyn Brown has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Laura Fernández Landó, Juan P. Frías, Xuewei Cui, Bing Liu, Julio Rosenstock, Federico C. Pérez Manghi, Brandon K. Bergman, Melanie J. Davies, Ross Bray and Ángel Rodríguez. Their work appears in journals such as The FASEB Journal, The Journal of Clinical Endocrinology & Metabolism, Cardiovascular Diabetology, Diabetes and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.